Dtsch Arztebl Int
The most recent articles from:
Dtsch Arztebl Int
-
Practice Guideline
Clinical Practice Guideline: Diffuse Large B-Cell Lymphoma and Related Entities—Diagnosis, Treatment, and Follow-Up.
Diffuse large B-cell lymphoma (DLBCL) is the most common malignant B-cell neoplasm, with an incidence of 5.6 per 100 000 persons per year and a mean age of onset of approximately 65 years. It is an aggressive type of non-Hodgkin's lymphoma requiring urgent treatment with curative intent. Evidence-based guidelines have not been available to date. ⋯ This clinical practice guideline on the diagnosis, treatment, and followup of patients with DLBCL and related entities provides a standardized clinical management approach, identifies areas where improvement would be desirable, and can serve as a basis for the development of further studies.